Show simple item record

dc.contributor.authorGrau, Santiago
dc.contributor.authorHernández Baeza, Sergi
dc.contributor.authorLimón, Enric
dc.contributor.authorCalbo, Esther
dc.contributor.authorHorcajada, Juan P.
dc.contributor.authorCatalan Infection Control and Antimicrobial Stewardship National Program (VINCat-PROA)
dc.date.accessioned2022-10-04T13:59:00Z
dc.date.available2022-10-04T13:59:00Z
dc.date.issued2022
dc.identifier.citationGrau, Santiago; Hernández Baeza, Sergi; Limón, Enric [et al.]. Impact of changes in the WHO’s 2019 update of DDDs on the measurement of adult hospital antibacterial consumption in Catalonia (Spain), 2008–18. JAC - Antimicrobial Resistance, 2022, 2(4), [p. 1-5]. Disponible en: <https://academic.oup.com/jacamr/article/2/4/dlaa079/5925473>. Fecha de acceso: 4 oct. 2022. DOI: 10.1093/jacamr/dlaa079ca
dc.identifier.issn2632-1823ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/3433
dc.description.abstractObjectives: In 2019 the WHO fully adopted new DDD values. The objective of this study is to analyse their impact on the measurement of consumption of antibacterials in hospitals participating in the Catalan Infection Control and Antimicrobial Stewardship National Program (VINCat-PROA) in Catalonia (Spain) between 2008 and 2018. Methods: The anatomical therapeutic chemical/DDD system was used to monitor adult hospital antibacterial consumption expressed in DDD/100 bed-days. Consumption from 2008 to 2018 was calculated using both pre- and post-update DDD values. Differences were calculated as the percentage variation in DDD/100 bed-days and analysed with Student’s t-test. Simple linear regressions were performed to evaluate the trends in adult antimicrobial consumption over the study period. Results: The overall consumption according to post-update DDD values decreased by 12.2% (P < 0.001) compared with the pre-update DDD values. Penicillins (−19.6.%; P < 0.001) and carbapenems (−19.0%; P = 0.023) showed the greatest reduction, followed by cephalosporins (−7.7%; P = 0.021) and quinolone antibacterials (−7.7%; P = 0.017). ICU services showed the greatest overall reduction (−13.1%; P < 0.001). From 2008 to 2018 there was a statistically significant decrease in consumption of penicillins and quinolone antibacterials and a statistically significant increase in cephalosporin and carbapenem consumption with both pre- and post-update DDD values. There were no variations in the ranking of consumption between the pre- and post-update DDD values. Conclusions: The WHO’s updates of DDDs have had a significant impact on the measurement of antibacterial consumption. In our region, they have corrected an overestimation of penicillin and carbapenem consumption amounting to 19%. It is essential to bear these findings in mind for an accurate assessment of temporal trends and benchmarking.en
dc.format.extent5ca
dc.language.isoengca
dc.publisherOxford University Pressca
dc.relation.ispartofJAC - Antimicrobial Resistanceca
dc.relation.ispartofseries2;4
dc.relation.urihttps://academic.oup.com/jacamr/article/2/4/dlaa079/5925473ca
dc.rightsVC The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comen
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.otherPenicilinaes
dc.subject.otherCarbapenemes
dc.subject.otherCefalosporinases
dc.subject.otherAdultoes
dc.subject.otherQuinolonases
dc.subject.otherEspañaes
dc.subject.otherOrganización Mundial de la Saludes
dc.subject.otherAgentes antibacterianoses
dc.subject.otherPenicil·linaca
dc.subject.otherCarbapenemca
dc.subject.otherCefalosporinesca
dc.subject.otherQuinolonesca
dc.subject.otherAdultesca
dc.subject.otherEspanyaca
dc.subject.otherOrganització Mundial de la Salutca
dc.subject.otherAgents antibacteriansca
dc.subject.otherPenicillinen
dc.subject.otherCarbapenemen
dc.subject.otherCephalosporinsen
dc.subject.otherAdulten
dc.subject.otherQuinolonesen
dc.subject.otherSpainen
dc.subject.otherWorld Health Organizationen
dc.subject.otherAnti-bacterial agentsen
dc.titleImpact of changes in the WHO’s 2019 update of DDDs on the measurement of adult hospital antibacterial consumption in Catalonia (Spain), 2008–18en
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc61ca
dc.identifier.doihttps://dx.doi.org/10.1093/jacamr/dlaa079ca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

VC The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint